DE69726071D1 - Pharmazeutische Zusammensetzung zur Verhütung und/oder Behandlung von Krankheiten mit Bezug auf Apoptose - Google Patents

Pharmazeutische Zusammensetzung zur Verhütung und/oder Behandlung von Krankheiten mit Bezug auf Apoptose

Info

Publication number
DE69726071D1
DE69726071D1 DE69726071T DE69726071T DE69726071D1 DE 69726071 D1 DE69726071 D1 DE 69726071D1 DE 69726071 T DE69726071 T DE 69726071T DE 69726071 T DE69726071 T DE 69726071T DE 69726071 D1 DE69726071 D1 DE 69726071D1
Authority
DE
Germany
Prior art keywords
apoptosis
prevention
treatment
pharmaceutical composition
diseases related
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69726071T
Other languages
English (en)
Other versions
DE69726071T2 (de
Inventor
Qing You Li
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tobishi Pharmaceutical Co Ltd
Original Assignee
Tobishi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tobishi Pharmaceutical Co Ltd filed Critical Tobishi Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DE69726071D1 publication Critical patent/DE69726071D1/de
Publication of DE69726071T2 publication Critical patent/DE69726071T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/855—Proteins from animals other than mammals or birds
    • Y10S530/856—Snakes; venom

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69726071T 1996-08-29 1997-08-28 Pharmazeutische Zusammensetzung zur Verhütung und/oder Behandlung von Krankheiten mit Bezug auf Apoptose Expired - Lifetime DE69726071T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP22795396A JP3866800B2 (ja) 1996-08-29 1996-08-29 アポトーシス関連疾患の予防及び／又は治療薬
JP22795396 1996-08-29

Publications (2)

Publication Number Publication Date
DE69726071D1 true DE69726071D1 (de) 2003-12-18
DE69726071T2 DE69726071T2 (de) 2004-09-02

Family

ID=16868859

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69726071T Expired - Lifetime DE69726071T2 (de) 1996-08-29 1997-08-28 Pharmazeutische Zusammensetzung zur Verhütung und/oder Behandlung von Krankheiten mit Bezug auf Apoptose

Country Status (7)

Country Link
US (2) US6106830A (de)
EP (1) EP0826374B1 (de)
JP (1) JP3866800B2 (de)
CN (1) CN100408092C (de)
AU (1) AU726565B2 (de)
CA (1) CA2212954A1 (de)
DE (1) DE69726071T2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3866800B2 (ja) * 1996-08-29 2007-01-10 東菱薬品工業株式会社 アポトーシス関連疾患の予防及び／又は治療薬
WO2001094420A1 (en) 2000-06-05 2001-12-13 The Trustees Of Columbia University In The City Of New York Identification and use of human bone marrow-derived endothelial progenitor cells to improve myocardial function after ischemic injury
US6858587B2 (en) * 2001-11-02 2005-02-22 Novo Nordisk Pharmaceuticals, Inc. Use of tissue factor agonist or tissue factor antagonist for treatment of conditions related to apoptosis
US20030199464A1 (en) * 2002-04-23 2003-10-23 Silviu Itescu Regeneration of endogenous myocardial tissue by induction of neovascularization
CN1605336A (zh) * 2003-10-10 2005-04-13 中国医学科学院药物研究所 左旋丁基苯酞在制备预防和治疗脑梗塞的药物中的应用
KR101777414B1 (ko) * 2005-09-30 2017-09-11 토비시 파마슈티칼 컴패니 리미티드 줄기세포 및/또는 전구세포의 활성화제
CN101274096B (zh) * 2007-03-29 2011-04-27 上海万兴生物制药有限公司 一种稳定的巴曲酶药物组合物
WO2008119203A1 (fr) 2007-03-30 2008-10-09 Shanghai Wanxing Biopharmaceuticals, Co., Ltd. Batroxobine recombinante purifiée à haute activité spécifique

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH586233A5 (de) * 1971-01-18 1977-03-31 Pentapharm Ag
US5500432A (en) * 1990-08-01 1996-03-19 The Scripps Research Institute Induction and inhibition of apoptosis
WO1993025683A1 (en) * 1992-06-12 1993-12-23 Massachusetts Institute Of Technology A gene which prevents programmed cell death
WO1995003054A1 (en) * 1993-07-23 1995-02-02 Lxr Biotechnology Inc. Methods of treating apoptosis and associated conditions
JP4140981B2 (ja) * 1994-12-26 2008-08-27 東菱薬品工業株式会社 再狭窄症及び動脈硬化症治療薬
JP3742675B2 (ja) * 1995-06-28 2006-02-08 東菱薬品工業株式会社 虚血−再灌流障害の予防および治療薬
JP3866800B2 (ja) * 1996-08-29 2007-01-10 東菱薬品工業株式会社 アポトーシス関連疾患の予防及び／又は治療薬

Also Published As

Publication number Publication date
CA2212954A1 (en) 1998-02-28
EP0826374A3 (de) 1999-03-03
DE69726071T2 (de) 2004-09-02
US6106830A (en) 2000-08-22
AU3607597A (en) 1998-03-05
EP0826374A2 (de) 1998-03-04
CN1179980A (zh) 1998-04-29
JPH1072367A (ja) 1998-03-17
CN100408092C (zh) 2008-08-06
JP3866800B2 (ja) 2007-01-10
AU726565B2 (en) 2000-11-09
US6399576B1 (en) 2002-06-04
EP0826374B1 (de) 2003-11-12

Similar Documents

Publication Publication Date Title
DE69117117T2 (de) Reinigungszusammensetzung zur Vorbeugung und Milderung von Hautreizungen
DE69332732T2 (de) Pharmazeutische Zusammensetzung und Methode zur Behandlung von Hyperlipidämie und Arterioskerose
DE4497905T1 (de) Pharmazeutische Zusammensetzung zur Prävention und Behandlung des Motion-Sickness-Syndroms
DE69230046T2 (de) 2-Bromomelatonin zur Behandlung von Schlafstörungen
NO994014D0 (no) Arylsulfonamider og analoger derav og deres anvendelse for behandling av neurodegenerative sykdommer
UA26213C2 (uk) Засіб для профілактики та лікуваhhя остеопорозу та фармацевтичhа композиція hа їх осhові
ATE331522T1 (de) Zusammensetzung zur behandlung von atemwegs- und hauterkrankungen mit mindestens einem leukotrienantagonist und mindestens einem antihistaminikum
DE60023128D1 (de) Pyrazolecarboxamide zur behandlung von fettleibigkeit und anderen erkrankungen
FI990171A (fi) Uusia yhdisteitä ja koostumuksia tryptaasiaktiivisuuden liittyvien tautien hoitamiseksi
DE19580261D2 (de) Pharmazeutische Zubereitungen und Arzneistoffe zur Prävention und Behandlung endothelialer Dysfunktion
DE69532066D1 (de) Arzneimittel zur Behandlung von Restenosis und Gefässsklerose
DE69620691D1 (de) Therapeutisches Mittel zur Behandlung der Hypercholesterinämie
DE69726071D1 (de) Pharmazeutische Zusammensetzung zur Verhütung und/oder Behandlung von Krankheiten mit Bezug auf Apoptose
DE69939075D1 (de) Pharmazeutische Zusammenstellung zur Vorbeugung und Behandlung von mit Zellkrankheiten des Augenhintergrundes zusammenhängenden Krankheiten
DE69825319D1 (de) Präparat zur vorbeugung und behandlung von entzündungen
DE69120933T2 (de) Topische Anwendung von Glycosaminoglykane zur Prävention und Behandlung der Zervikal- oder Vaginalerkrankungen
DE69822276T2 (de) Kräuter formulierung mit therapeutischer und kosmetischer verwendung zur behandlung von allgemeinen hauterkrankungen
NO922531D0 (no) Middel for forhindring av og behandling av fiskesykdommer
DE29620182U1 (de) Humantherapeutisches Erzeugnis zur Behandlung und/oder Vorbeugung von Krankheiten durch Dämpfe von ätherischen Ölen
DE69418931T2 (de) Verwendung von VIP und deren Analogen und Fragmenten zur Behandlung von neurodegenerativen Krankheiten
DE59309732D1 (de) Arzneimittel zur behandlung und prophylaxe von knochen- und gelenkserkrankungen
DE60107900D1 (de) Pharmazeutische Zusammensetzung und Nahrungsmittel zur Behandlung von Gehirnödem
DE69739190D1 (de) Arzneimittel zur behandlung von oculären kreislauferkrankungen
DE69417724T2 (de) 5-Morpholinmethyl-3-(4-chlorbenzylidenamin)-2-oxazolidinon enthaltende pharmazeutische Zubereitung und ihre Verwendung zur Behandlung von Erkrankungen des ZNS
ATE183090T1 (de) Arzneimittel zur behandlung und prophylaxe von knochen- und gelenkserkrankungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition